Comparison of Pamidronate With Zoledronic Acid for Transplant Related Bone Loss Prevention
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to see whether zoledronic acid is better than pamidronate to
treat low bone density in heart and lung transplant patients.